jeudi 27 avril 2017

Onco Actu du 27 avril 2017

3.1 Tabac

Plain cigarette packaging could drive 300,000 Britons to quit smoking [The Guardian]

UK plain cigarette pack law seen cutting number of smokers by 300,000 [Reuters]

3.1.1 Tabac - e-cigs

U.S. House bill would exempt e-cigarettes from tobacco regulations [Reuters]

4. Dépistage, diagnostic et pronostic

Five years wisely: A look at Choosing Wisely’s effort to reduce unnecessary medical care [HealthNewsReview]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

FDA issues warning letter to “holistic” practitioner offering thermography for breast cancer detection [Science-Based Medicine]

4.12 Biopsies liquides

Blood tests track lung cancer gene changes, aiding treatment [STAT]

Experimental blood test could offer a glimpse of the future for doctors treating lung cancer [Cancer Research UK]

Liquid-biopsies success highlights power of combining basic and clinical research [Nature]

'Exciting' blood test spots cancer a year early [BBC News]

DNA-based test can spot cancer recurrence a year before conventional scans [The Guardian]

4.2 Dép., diag. & prono. - Génome

Tracing genetic chaos in 100 lung cancer patients could help predict survival [Cancer Research UK]

4.5 Dép., diag. & prono. - Colorectal

‘OK to wait’ or ‘Delay at your own risk?’ Headspinning headlines on same colonoscopy study [HealthNewsReview]

Ok to wait for colonoscopy after positive fecal test results [Reuters]

5. Traitements

Cancer-causing DNA is found in some stem cells being used in patients [STAT]

5.10 Traitements - Essais

Whose Data Are They Anyway? Can a Patient Perspective Advance the Data-Sharing Debate? [NEJM]

Bridging the Data-Sharing Divide — Seeing the Devil in the Details, Not the Other Camp [NEJM]

5.12 Immunothérapies

Roswell Park-Led Team Identifies Tumor Marker for Aggressive Ovarian Cancer [Roswell Park]

5.12.2 Immunothérapies - CAR-T

Novartis confirms that Juliet CAR-T data out in June [FierceBiotech]

5.12.3 Immunothérapies-combinaisons

Silently Affecting the Immune System? [In the Pipeline]

5.2 Pharma

Way over budget and years late — AstraZeneca’s massive HQ project offers a troubling symbol [EndPoints]

AstraZeneca third-line lung cancer trial delayed by few months [Reuters]

5.2.3 Pharma - économie

The top 10 pharma R&D budgets in 2016 [FierceBiotech]

Bristol-Myers beats Wall St estimates, helped by Cancer drug Opdivo [Reuters]

Novartis takes a $200M hit to write off a flop as execs spell out a cautious R&D strategy [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Barcelona pitches ready-to-go home for EMA in iconic building, adds to calls for quick decision to minimize risk [FierceBiotech]

FDA Takes Action Against Fraudulent Cancer Products [FDA Voice]

FDA takes action against 14 companies for selling illegal cancer treatments [FDA]

5.4 Traitements - Economie

Takeda’s Ninlaro rejected by NICE for multiple myeloma [PharmaTimes]

6. Lutte contre les cancers

Cold caps to fight hair loss from chemotherapy: Will the idea catch on here? [Georgia Health]

The NCRI partnership launches new five-year strategy to accelerate progress in cancer research [Cancer Research UK]

6.1 Observation

There’s more to emergency diagnoses than GPs ‘failing cancer patients’ [Cancer Research UK]

Pregnancy complications await childhood cancer survivors [Reuters]

6.10.1 Politiques (USA)

ASCO Applauds California as First State to Consider Oncology Clinical Pathways Legislation [ASCO]

6.11 Patients

The survivors: How an experimental treatment saved patients and changed medicine [STAT]

6.12 Ethique

The Broad Institute is testing the limits of what ‘nonprofit’ means [STAT]

6.5 Médecines alternatives

The failure of the Texas Medical Board: Houston cancer quack Stanislaw Burzynski is back in business [Respectful Insolence]

6.6 Publications

Mark Zuckerberg And Priscilla Chan's Philanthropy Backs Effort To Change Scientific Publishing [Forbes]

A troubling new way to evade plagiarism detection software. (And how to tell if it’s been used.) [Rertraction Watch]

Reviewers are blinkered by bibliometrics [Nature]

New services to support open research [BioMed Central]

BioRxiv preprint server gets cash boost from Chan Zuckerberg Initiative [Nature]

6.8 Communication

How hype can mislead cancer patients, families [CNN]

6.9 Controverses

After protests, a fired cancer center director gets her job back [STAT]

Cancer institute reinstates director after uproar from staff and funder [Science]

University of Utah reinstates Beckerle as CEO and director of Huntsman Cancer Institute [The Cancer Letter]